Perspective Therapeutics, Inc. CATX
- bamzireotide navoxetan — Neuroendocrine Tumors Phase 1
- VMT-α-NET — Meningioma Phase 1
SSTR2 (1 companies · 2 programs)
Companies with an active program directed at SSTR2.
Companies with an active program directed at SSTR2.